CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AstraZeneca LP v. Watson Laboratories Inc.

1:16-cv-00338

Overview

Case Number 1:16-cv-00338
Filing Date 2016-05-09
Status Terminated
Termination Date 2018-03-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:0145
Jury Demand None

Parties

Defendant

Watson Laboratories Inc. Operating Company

Represented By

1 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

AstraZeneca AB NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

AstraZeneca LP NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Plaintiff

AstraZeneca Pharmaceuticals, LP NPE (Individual / Inventor)

Represented By

3 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

AstraZeneca UK Limited NPE (University / Research)

Represented By

3 Attorneys Listed

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Benjamin A. Smyth

McCarter & English, LLP

Tel: +1 (302) 984-6300

Renaissance Centre, 405 N. King Street, 8th Floor

Michael P. Kelly

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 5 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (5 found):
U.S. Courts: 5
U.S. District Court 2015-11-16
1:15-cv-01056

AstraZeneca LP v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2015-11-16
1:15-cv-01058

AstraZeneca LP v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2015-11-16
1:15-cv-01057

AstraZeneca LP v. Prinston Pharmaceutical Inc.

Asserted Patent
Status: DED
U.S. District Court 2015-10-30
1:15-cv-01001

AstraZeneca LP v. InvaGen Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2015-10-30
1:15-cv-01000

AstraZeneca LP v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6525060
Triazolo(4,5-d)pyrimidine compounds
Filed: 1999-12-02
Issued: 2003-02-25
Expired (Term Ended)
Expires: 2019-12-02
US7250419
Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
Filed: 2005-09-21
Issued: 2007-07-31
Expired (Term Ended)
Expires: 2025-09-21
US7265124
Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound
Filed: 2005-10-03
Issued: 2007-09-04
Expired (Term Ended)
Expires: 2021-07-09

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Watson Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1928141.) - filed by AstraZeneca LP, AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP, AstraZeneca AB.(Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(aah) (Entered: 05/10/2016)

Entry #1 • 2016-05-09
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah) (Entered: 05/10/2016)

Entry #2 • 2016-05-09
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/4/2016. Date of Expiration of Patent: See attached form.Thirty Month Stay Deadline: 1/20/2019. (aah) (Entered: 05/10/2016)

Entry #3 • 2016-05-09
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,525,060; 7,250,419; 7,265,124;(aah) (Entered: 05/10/2016)

Entry #4 • 2016-05-09
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca LP filed by AstraZeneca LP.(aah) (Entered: 05/10/2016)

Entry #5 • 2016-05-09
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc